Synthesis and binding affinities for 5-HT(1A), 5-HT(2A) and 5-HT(2C) receptors of a series of 1- and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3- triazole derivatives

European Journal of Medicinal Chemistry

Volumn 34, Issue 9, 1999, Pages 719-727

  Caliendo, Giuseppe ^a   Fiorino, Ferdinando ^a   Grieco, Paolo ^a   Perissutti, Elisa ^a   Santagada, Vincenzo ^a   Albrizio, Stefania ^b   Spadola, Loredana ^b   Bruni, Giancarlo ^c   Romeo, Maria Rosaria ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

5 HT receptor; Arylpiperazines; Serotonin; Synthesis

Indexed keywords

1,2,3 TRIAZOLE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; LIGAND BINDING; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0032882058     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)00221-4     Document Type: Article

References (21)

1. Baumgarten H.G., Gothert M. Serotoninergic Neuron and 5-HT Receptors in the CNS. 1997;Springer-Verlag, Berlin.
2. van Wijngaarden I., Soudin W. Serotonin Receptors and Their Ligands. 1997;Elsevier, Amsterdam.
3. Hamon M., Gozlan H., El Mestikawy S., Emerit M.B., Boslanos F., Schecther L. Am. N.Y. Acad. Sci. 600:1990;114-131.
4. Eison A.S., Eison M.S. Prog. Neuropsychopharmacol. Biol. Psychiatry. 18:1994;47-62.
5. Eison M.S. Psychopathology. 1:1989;13-20.
6. Glennon R.A. Drug Dev. Res. 26:1992;251-274.
7. van Steen B.J., van Wijngaarden I., Tulp M.T.M., Soudijn W. J. Med. Chem. 36:1993;2751-2760.
8. Caliendo G., Greco G., Grieco P., Novellino E., Perissutti E., Santagada V., Barbarulo D., De Blasi A. Eur. J. Med. Chem. 31:1996;207-213.
9. Kenneth B., Heilbron I.M., Jones E.R.H., Weedon B.C.L. J. Chem. Soc. Part I. 1946;39-45.
10. Nesmeyanov A.N., Rybinskaya M.I. Dokl. Akad. Nauk. SSSR. 158:1964;408-410.
11. Livi O., Biagi G., Ferretti M., Lucacchini A., Barili P.L. Eur. J. Med. Chem. -Chim. Ter. 18:1983;471-475.
12. Biagi G., Ferretti M., Livi O., Scartoni V., Lucacchini A., Mazzoni M. Il Farmaco Ed. Sc. 41:1986;388-400.
13. Lòpez-Rodrìguez M.L., Rosado M.L., Benhamù B., Morcillo M.J., Feràndez E., Schaper K.J. J. Med. Chem. 40:1997;1648-1656.
14. Lòpez-Rodrìguez M.L., Rosado M.L., Benhamù B., Morcillo M.J., Sanz A.M., Orensanz L., Beneitez M.E., Fuentes J.A., Manzanares J. J. Med. Chem. 39:1996;4439-4450.
15. Perrone R., Berardi F., Leopoldo M., Tortorella V. J. Med. Chem. 39:1996;3195-3202.
16. Schlegel J.R., Peroutka S.J. Biochem. Pharmacol. 35:1986;1943-1949.
17. Herndon J.L., Ismaiel A., Ingher S.P., Teitler M., Glennon R.A. J. Med. Chem. 35:1992;4903-4910.
18. Billard W., Ruperto V., Grosby G., Iorio L.C., Barnett A. Life Sci. 35:1985;1885-1893.
19. Creese I., Schneider R., Snyder S.H. Eur. J. Pharmacol. 46:1977;377-381.
20. Greengrass P., Brenner R. Eur. J. Pharmacol. 55:1979;323-326.
21. Perry B.D., U'Prichard D.C. Eur. J. Pharmacol. 76:1981;461-464.